BR9811657A - Clonagem usando-se núcleos doadores oriundos de células diferenciadas não-carentes de soro - Google Patents

Clonagem usando-se núcleos doadores oriundos de células diferenciadas não-carentes de soro

Info

Publication number
BR9811657A
BR9811657A BR9811657-6A BR9811657A BR9811657A BR 9811657 A BR9811657 A BR 9811657A BR 9811657 A BR9811657 A BR 9811657A BR 9811657 A BR9811657 A BR 9811657A
Authority
BR
Brazil
Prior art keywords
cells
differentiated
serum
production
cloning
Prior art date
Application number
BR9811657-6A
Other languages
English (en)
Portuguese (pt)
Inventor
Steven L Stice
Jose Cibelli
James M Robl
Paul Golueke
F Abel Ponce De Leon
D Joseph Jerry
Original Assignee
Univ Massachusetts Public Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Massachusetts Public Inst filed Critical Univ Massachusetts Public Inst
Publication of BR9811657A publication Critical patent/BR9811657A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C12N15/8771—Bovine embryos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/02—Cells from transgenic animals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/04—Cells produced using nuclear transfer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
BR9811657-6A 1997-07-03 1998-06-24 Clonagem usando-se núcleos doadores oriundos de células diferenciadas não-carentes de soro BR9811657A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88828397A 1997-07-03 1997-07-03
PCT/US1998/012800 WO1999001163A1 (fr) 1997-07-03 1998-06-24 Clonage a l'aide de noyaux donneurs a partir de cellules differentiees ne presentant pas de carence serique

Publications (1)

Publication Number Publication Date
BR9811657A true BR9811657A (pt) 2000-09-05

Family

ID=25392916

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9811657-6A BR9811657A (pt) 1997-07-03 1998-06-24 Clonagem usando-se núcleos doadores oriundos de células diferenciadas não-carentes de soro

Country Status (9)

Country Link
EP (1) EP1017422A4 (fr)
JP (1) JP2001509361A (fr)
CN (2) CN1265599A (fr)
AU (1) AU8154398A (fr)
BR (1) BR9811657A (fr)
CA (1) CA2294916A1 (fr)
IL (1) IL133786A0 (fr)
NZ (1) NZ502129A (fr)
WO (1) WO1999001163A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235969B1 (en) * 1997-01-10 2001-05-22 University Of Massachusetts Cloning pigs using donor nuclei from non-quiescent differentiated cells
WO1999036510A1 (fr) * 1998-01-16 1999-07-22 Agrobiogen Gmbh Transfert de noyau efficace avec des fibroblastes foetaux
US6331659B1 (en) 1998-01-21 2001-12-18 University Of Hawaii Cumulus cells as nuclear donors
JP2002511234A (ja) * 1998-03-16 2002-04-16 リレグ ピーティーワイ リミテッド ブタの核移植
AUPP294898A0 (en) * 1998-04-15 1998-05-07 Monash University Method of nuclear transfer
EP1375654A3 (fr) * 1998-11-02 2008-01-16 GTC Biotherapeutics, Inc. Mammifères trangéniques et clonés
EP1818397A1 (fr) * 1998-11-02 2007-08-15 Trustees Of Tufts College Procéde pour le clonage des animaux
US6781030B1 (en) 1998-11-02 2004-08-24 Trustee Of Tufts College, Ballou Hall Methods for cloning mammals using telophase oocytes
WO2000025578A2 (fr) * 1999-04-26 2000-05-11 Trustees Of Tufts College Procedes de clonage des animaux
ES2338631T3 (es) 1999-03-04 2010-05-11 Revivicor, Inc. Modificacion genetica de celulas somaticas y usos de las mismas.
NZ508739A (en) * 1999-06-30 2002-11-26 Woo Suk Hwang Method for producing cloned tigers by employing inter-species nuclear transplantation technique
JP3652308B2 (ja) * 1999-06-30 2005-05-25 ソウル ナショナル ユニバーシティー インダストリー ファウンデーション クローンウシの生産方法
AU5577600A (en) * 1999-06-30 2001-01-31 Woo-Suk Hwang A method for producing human embryonic skin cells by employing an inter-species nuclear transplantation technique
CN1413250A (zh) * 1999-10-15 2003-04-23 先进细胞技术公司 用于生成分化祖细胞和谱系缺陷型胚胎干细胞的方法
DE10084883D2 (de) * 2000-06-08 2004-04-29 Trostner Jens Verfahren zur genetischen Rekonstruktion von menschlichen Organen
AU8470301A (en) 2000-08-03 2002-02-18 Wim-Van Schooten Production of humanized antibodies in transgenic animals
FR2814642B1 (fr) 2000-10-03 2005-07-01 Ass Pour Le Dev De La Rech En Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee
US20020168763A1 (en) * 2000-11-30 2002-11-14 Yan Wen Liang Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using same
ATE466089T1 (de) 2000-12-22 2010-05-15 Agronomique Inst Nat Rech Positionsunabhängige und gewebespezifische expression eines transgens in der milch eines transgen-tieres
EP1356035B1 (fr) * 2000-12-22 2011-03-16 Kyowa Hakko Kirin Co., Ltd. Methodes de clonage de mammiferes non humains a l'aide de chromatine donneuse reprogrammee ou de cellules donneuses reprogrammees
JP4381139B2 (ja) 2001-08-13 2009-12-09 エンブレクス，インコーポレイテッド 鳥類の卵の処理方法
EP1490487A4 (fr) * 2002-04-01 2007-08-29 Gtc Biotherapeutics Inc Procede permettant la selection de lignees cellulaires convenant pour le transfert de noyau chez les especes mammiferes
US7612250B2 (en) 2002-07-29 2009-11-03 Trustees Of Tufts College Nuclear transfer embryo formation method
PE20081216A1 (es) 2006-09-01 2008-09-04 Therapeutic Human Polyclonals Inc Expresion mejorada de la inmunoglobulina humana o humanizada en animales transgenicos no humanos
EP2267153A1 (fr) 2009-05-26 2010-12-29 Université Claude Bernard Lyon 1 Identification de la mutation du gène unc5c du récepteur de la nétrine-1 dans des cancers solides
WO2013010045A1 (fr) 2011-07-12 2013-01-17 Biotime Inc. Nouveaux procédés et formulations pour thérapie cellulaire orthopédique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1595195A (en) * 1993-12-23 1995-07-10 Abs Global, Inc. Embryonic stem cells as nuclear donors and nuclear transfer techniques to produce chimeric and transgenic animals
GB9517779D0 (en) 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
GB9517780D0 (en) * 1995-08-31 1995-11-01 Roslin Inst Edinburgh Biological manipulation
US5945577A (en) 1997-01-10 1999-08-31 University Of Massachusetts As Represented By Its Amherst Campus Cloning using donor nuclei from proliferating somatic cells
WO1999036510A1 (fr) * 1998-01-16 1999-07-22 Agrobiogen Gmbh Transfert de noyau efficace avec des fibroblastes foetaux

Also Published As

Publication number Publication date
NZ502129A (en) 2005-02-25
EP1017422A4 (fr) 2002-10-29
CN1265599A (zh) 2000-09-06
CN101003800A (zh) 2007-07-25
CA2294916A1 (fr) 1999-01-14
AU8154398A (en) 1999-01-25
JP2001509361A (ja) 2001-07-24
IL133786A0 (en) 2001-04-30
WO1999001163A1 (fr) 1999-01-14
EP1017422A1 (fr) 2000-07-12

Similar Documents

Publication Publication Date Title
BR9811657A (pt) Clonagem usando-se núcleos doadores oriundos de células diferenciadas não-carentes de soro
BR9811659A (pt) Clonagem de porcos usando-se núcleos doadores de células diferenciadas
BR9806872A (pt) Transferência nuclear com células diferenciadas doadoras fetais e adultas
Kaneda et al. Genetic evidence for Dnmt3a‐dependent imprinting during oocyte growth obtained by conditional knockout with Zp3‐Cre and complete exclusion of Dnmt3b by chimera formation
ATE318307T1 (de) Kultur einer zelllinieaus der inneren zellmasse von huftierembryonen.
DK1044262T3 (da) Könsspecifik inseminering af pattedyr med et lavt antal sædceller
BR9913643A (pt) Transgênese de mamìferos através de injeção intracitoplásmica de espermatozóides
BR0209028A (pt) Método de transferência nuclear
NZ505728A (en) Full term development of animals from enucleated oocytes reconstituted with adult somatic cell nuclei
Arat et al. Using cell banks as a tool in conservation programmes of native domestic breeds: the production of the first cloned Anatolian Grey cattle
Han et al. Overexpression of Tet3 in donor cells enhances goat somatic cell nuclear transfer efficiency
Nguyen et al. Heterogeneity of primordial germ cells
WO2000026357A3 (fr) Mammiferes transgeniques et clones
Ye et al. Caffeine and dithiothreitol delay ovine oocyte ageing
WO2001030980A3 (fr) Procedes et compositions ameliorant le potentiel de developpement d'oocytes et de zygotes
WO2001060152A3 (fr) Mammifere knockout transgenique non humain a gene ucp2 desactive
EP1375654A3 (fr) Mammifères trangéniques et clonés
BR0010588A (pt) Oócitos enucleados de telofase para transferência nuclear
Shimozawa et al. Direct production of gene-targeted mice from ES cells by nuclear transfer and gene transmission to their progeny
Nevoral et al. Epigenome Modification and Ubiquitin‐Dependent Proteolysis During Pronuclear Development of the Mammalian Zygote: Animal Models to Study Pronuclear Development
Urrego et al. Effect of centrifugation on plasma membrane and DNA of bovine spermatozoa
HUP0401692A2 (hu) Szomatikus embrió előállítása nyúl oocita felhasználsával
DE69940057D1 (de) Quelle für zellkerne zum kern-transfer
Sansinena et al. 52 INITIATION OF PREGNANCIES IN SOUTH AFRICAN RIVERINE RABBIT (BUNOLAGUS MONTICULARES) BY INTERSPECIES NUCLEAR TRANSFER USING ADIPOSE-DERIVED SOMATIC CELLS
Cocquet et al. The Multicopy Gene Sly Represses the Sex Chromosomes in the Male Mouse

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: DE ACORDO COM O ART. 36 DA LPI (LEI 9279/96) 2O, O PEDIDO VOLTA A EXAME SENDO CONSIDERADO NAO PATENTEAVEL PELAS RAZOES EXPOSTAS NO PARECER TECNICO ANTERIOR. PORTANTO, INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO - DE ACORDO COM O ART. 8O DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.